StockData
Olema Oncology, Inc. logo

Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.06−0.16 (-2.22%)

Close on Nov 18, 2026Market cap $617.73MP/E –Yield –

Olema Oncology revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Olema Oncology

Olema Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Olema Oncology figures

See a number that looks wrong?